Stocktoria
Wave Life Sciences Ltd. WVE
Wave Life Sciences Ltd. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $42.7M | $108.3M | $113.3M | $3.6M | $41.0M | $20.1M | $16.0M | $14.4M | $3.9M | $1.5M |
| R&D expense | $182.8M | $159.7M | $130.0M | $115.9M | $121.9M | $130.9M | $175.4M | $134.4M | $79.3M | $40.8M |
| Operating income | -$215.4M | -$110.4M | -$68.0M | -$162.7M | -$127.0M | -$153.4M | -$208.3M | -$159.5M | -$102.4M | -$55.7M |
| Income tax | $0 | $0 | -$677,000 | $681,000 | -$204,000 | -$841,000 | $0 | $69,000 | $842,000 | $482,000 |
| Net income | -$204.4M | -$97.0M | -$57.5M | -$161.8M | -$122.2M | -$149.9M | -$193.6M | -$146.7M | -$102.0M | -$55.7M |
| EPS (diluted) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | — | — | — | — | — |
| Operating cash flow | -$187.5M | -$151.0M | -$19.4M | -$127.8M | -$89.0M | -$116.0M | -$188.2M | -$22.9M | -$83.7M | -$31.9M |
| Free cash flow | -$188.2M | -$152.0M | -$20.5M | -$129.1M | -$89.6M | -$117.3M | -$192.1M | -$32.8M | -$102.6M | -$37.5M |
| Cash & equivalents | $602.1M | $302.1M | $200.4M | $88.5M | $150.6M | $184.5M | $147.2M | $174.8M | $142.5M | $150.3M |
| Total assets | $638.5M | $352.2M | $274.9M | $146.4M | $207.0M | $279.2M | $284.2M | $295.9M | $181.8M | $164.8M |
| Total liabilities | $112.3M | $134.8M | $227.4M | $183.6M | $166.6M | $188.6M | $212.6M | $214.7M | $34.4M | $22.1M |
| Shareholders' equity | $518.4M | $209.5M | $39.6M | -$45.1M | $32.5M | $82.8M | $63.7M | $73.3M | $139.6M | $134.6M |
Growth · year-over-year · Revenue CAGR 45.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -60.5% | -4.4% | +3005.1% | -91.1% | +104.0% | +25.6% | +10.9% | +270.3% | +162.2% | +877.0% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.